Length: 29:24
Guest: Jon Bigelow, Executive Director, Coalition for Healthcare Communications
Host: Jason E. Carris
Jon Bigelow is executive director of the Coalition for Healthcare Communication. The coalition membership includes medical publishers, advertising agencies, marketing firms, scientific communications firms, point of care content providers, and digital platforms.
As big data and data security have grown in the past decade, the federal government has been “reluctant to get involved,” says Bigelow, past president and current board member of the Association of Medical Media. He says many of the companies involved in data are monopolies, yet the government has “not taken the same anti-trust stance as it did previously with Standard Oil, the railroads, or Bell breakups.”
Companies that harvest and monetize data “have been allowed to self-regulate” as the government has, for the most part, played a “passive, hands-off role. But the anger has been building the past few years.”
He notes concerns with security breaches and digital platforms, like Facebook, that have allowed the use of personal data for purposes the consumer never intended. “The Cambridge Analytica event was a big deal.”
Data privacy policy was largely driven by the European Union and its GDPR, which “essentially added more specifics to the definition of what is personal data, instituted a very rigorous opt-in mechanism, and provided, at least initially, severe penalties,” he says.
In 2019, California passed the first sweeping legislation (CCPA) in the U.S. aimed at protecting consumers’ data. “It was very quickly designed legislation,” Bigelow says. “To this day, it is still being clarified by their Attorney General. ... It is enforceable as of July 1, 2020.”
CCPA improved mechanisms for consent, but has “more of an opting-out emphasis,” he says, “so that a consumer has the right to know what data is being collected, where it was collected from, what is being done with that data, by whom, and the ability to opt-out.”
The big problem is the potential for every state to create its own privacy law(s), which is almost “untenable” from an industry perspective. “The second big issue is the burden on the consumer/user,” Bigelow says. “You don’t really know what you are agreeing to… to think simply clicking ‘I Agree’ is consent is laughable.”
Bigelow does see light at the end of the tunnel, in terms of much-needed federal regulations vs. a patchwork of state laws. Despite the dysfunction in Washington, D.C., there appears to be bipartisan agreement that “one, something needs to be done to protect the privacy and security of individuals data; and second, it needs to be done at a federal level. This is one of the few areas where there is consensus.”
Medical media should take note of work from Privacy for America, an industry group attempting to establish broad principles for a privacy law, of which many of the principles are being used in the dozens of bills circulating the Beltway. The principles would act as federal guard rails, the same as safety standards for automobiles, Bigelow explains. Key pillars of the effort:
When asked about the privacy questions the coalition’s membership is asking: “For medical publishers and media placement firms, the big issue was with the Colorado legislation. … Advertising agency concerns were on the cyber security side, in terms of who is liable when data is breached. … Scientific communications firms are concerned with the use of algorithms to try to discern patterns in the data that might not be visible. Example: identify patients with a rare disease and being able to target communications to them or include them in a clinical trial. … The publication planning world is very much under pressure to get all clinical trial results into the literature very quickly, including negative results, and include full data sets. There is a lot of concern whether, in fact, they can put the full data sets in the public purview.”
Bigelow says he thinks the government’s view of data as a “public good” is changing for the positive, even though it might narrow an individual’s right to privacy. Whether it is Google and Apple tracking individuals’ movement during Covid-19 or clinical trials for rare disease research, or new safe harbor laws for rare disease research, he says data as a public good “is an issue that is going to be re-evaluated.”
Resources:
Subscribe: Add the AMM Conversation to your playlist on Apple Podcasts, Google Podcasts, Spotify, Stitcher or wherever you enjoy podcasts.
Next: Ep. 4 will conclude the data privacy discussions.
Contact us: AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com.
S4, E5: Amy Houck and Brad Einarsen dive deep into successful tactics for engaging physicians via social media
S4, E4: Doximity's Amit Phull, MD, Reddit's Laura Nardella, and Sermo's Erin Fitzgerald discuss the acceleration of social media usage amongst healthcare professionals
S4, E3: Dr. Eric Gantwerker discusses the broad impact "video games for doctors" is having on medical education
S4, E2: GSK's Ryan Billings, AstraZeneca's Angela Horstmann, and Ipsen's Paul Murasko discuss HCP engagement with social and multimedia
S4, E1: Kevin Bolum, Todd Ware, and Tom McCabe discuss the American College of Physicians' biggest wins with HCP-focused multimedia
Coming Soon: Season 4, Strategies to Engage HCPs Via Social and Multimedia
S3, E5: Frontline's Mike Guire, Tracey Sears, and Devin Gregorie debate medical media landscape for 2021 and beyond
S3, E4: James Brady shares insights on medical media's past, present, and future
S3 E3 TrendMD's Paul Kudlow shares insights on digital marketing from the physician viewpoint
S3, E2 R.J. Lewis and Amy Turnquist discuss medical media trends, how data is table stakes, and opportunity in a "cookie-less" future
S3, E1 Highlights from AMM's Pharma Forecast 2021 panel with GSK's Jim DeLash and Merck's Lori Hancock-Holland
Season 3 Trailer: Exploring Emerging Trends in Medical Marketing and HCP Engagement
S2, E5: Eugene Lee, Jim Woodland, and Sima Sherman dive deep on the"new normal" in medical media
Industry veteran Dora Shankman discusses the "new normal" in medical media
S2, E3: MedscapeLive!'s Benji Kayne discusses producing virtual events in the "New Normal of Medical Media"
S2, E2: Elsevier's Denis Conlon, Sumner Mering, Alejandro Alvarez discuss the new normal in medical media
S2, E1: Healio's Matt Holland, JoanMarie Stiglich, and John C. Carter discuss the "New Normal in Medical Media"
Season 2: The New Normal in Medical Media
S1, E4: Dr. Augustine Fou explains big tech's issue with data privacy, "bad actors" in digital advertising, and best practices for medical media
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Social Dallas Podcast
Change Church Podcast
Six Degrees with Kevin Bacon
Advocacy Scoop Podcast
Nonprofits Are Messy: Lessons in Leadership | Fundraising | Board Development | Communications